Pharmaceutical Industry Analysis and Statistics (since 2008

In the Q409 update of BMI?s India Pharmaceuticals & Healthcare report, we have introduced our 10-yearDrug Expenditure Forecast Model. The country?s US$14.23bn pharmaceutical market is forecast to reacha value of US$44.99bn by 2018, representing a compound annual growth rate (CAGR) of 12.20%. Themain ...

Industries : Healthcare, Pharmaceutical

Czech Republic Pharmaceuticals and Healthcare Report Q4 2009

$ 495
October 2009

The Czech Republic has one of the most developed and technologically advanced pharmaceutical marketsin Central & Eastern Europe (CEE). Despite the impact of the economic downturn, BMI believes thatCzech medicine sales growth will remain healthy, if not overly impressive, over the next five years,ref ...

Industries : Healthcare, Pharmaceutical

Estonia Pharmaceuticals and Healthcare Report Q4 2009

$ 495
October 2009

Estonia?s pharmaceutical market is unlikely to be a prime target for multinational drugmakers expandinginto foreign countries. Despite rapid economic growth in recent years, which has translated into strongheadline growth for pharmaceutical expenditure, the country?s population of just 1.34mn means ...

Industries : Healthcare, Pharmaceutical

Top 20 Cancer Therapy Brands Forecast

$ 15 200
October 2009

IntroductionThe cancer therapies market offers a high level of commercial reward to a handful of companies including Roche, Sanofi-Aventis, AstraZeneca, Novartis and Eli Lilly. Cancer therapy sales totaled over $38 billion in the seven major pharmaceutical markets in 2008, growing at a CAGR of 17.4% ...

Industries : Therapy

Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile

$ 5 700
October 2009

IntroductionThis analysis examines the historical and forecast performance for Chugai in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An i ...

Industries : Pharmaceutical

Allergan Inc.: PharmaVitae Profile

$ 5 700
October 2009

IntroductionThis analysis examines the historical and forecast performance for Allergan in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interacti ...

Industries : Pharmaceutical

Launching a medicine or a product in french pharmacies

$ 1 500
October 2009

Many foreign companies would like to sell their products, medicinal or not, to French pharmacies, but do not know how to go about doing so:¦ What are the different regulatory statuses?¦ How is the distribution of drugs organized in France?¦ What sales force can they rely on?¦ Who are the wholesa ...

Industries : Pharmacies and Drug Stores

RFID in Healthcare and Pharmaceuticals 2009-2019

$ 2 681
October 2009

The RFID business is growing so fast that few applicational sectors can beat that scorching rate of growth. Healthcare and pharmaceuticals is one of them thanks to the new tagging of drugs, real time location of staff and patients and other developments including automated error prevention. This un ...

Industries : Wireless Technology, Healthcare, Pharmaceutical

Drug Delivery Partnering Agreements in Pharma and Biotech

$ 2 119
October 2009

DescriptionThe Drug Delivery Partnering Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the drug delivery partnering agreements entered into by the worlds leading healthcare companies.The report provides a detailed understanding and analysis o ...

Industries : Drug Delivery Technology

Global Oxygen Therapy Industry

$ 950
October 2009

The global outlook series on Oxygen Therapy provides statistical anecdotes, market briefs, and concise summaries of research findings. The report offers an aerial view of the global oxygen therapy industry, identifies major short to medium term market challenges, and growth drivers. Regional markets ...

Industries : Therapy

Boosting Immunity Through Digestion: The Relation Among Probiotics, Prebiotics and Digestive Enzymes

$ 3 850
October 2009

Probiotic literally means ?for life.? The Joint Food and Agriculture Organization/World Health Organization defines probiotics as ?live microorganisms which, when administered in adequate amounts, confer a health benefit on the host.? Prebiotics are nondigestible carbohydrates that feed beneficial ...

Industries : Pharmaceutical

The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets

$ 3 995
October 2009

At their most basic level, wellness programs represent an attempt to encourage good health and thereby decrease utilization of health care products and services. They have evolved out of necessity from the current U.S. health care system, in response to a variety of factors including continually ri ...

Industries : Pharmaceutical

The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)

$ 3 500
October 2009

The anti-infective market is at a critical juncture. For the past 60 years, antibiotic drugs have turned bacterial infections into treatable conditions rather than the life-threatening scourges they once were. But the effectiveness of many antibiotics is waning dramatically, as more and more types ...

Industries : Pharmaceutical

PDGF-R Agonists and Antagonists

$ 375
October 2009

Product descriptionThe present Competitive Intelligence Report about PDGF-R agonists and antagonists provides a competitor evaluation in the field of platelet derived growth factor receptor (PDGF-R) or PDGF targeting molecules for wound healing, bone formation or treatment of cancer as of October 20 ...

Industries : Pharmaceutical

Immunotherapies and Vaccines for Nontraditional Indications

$ 2 995
October 2009

Novel applications of immunotherapies and vaccines beyond prevention and treatment of infectious diseases and cancer are reviewed. Those discussed typically target molecules not normally targeted by the immune system. This report:Covers a wide range of conditions for which immunotherapies may be eff ...

Industries : Pharmaceutical

Regenerative Medicines: Bone and Joint Applications

$ 4 850
October 2009

Provides a comprehensive overview of the global market for regenerative medicines for bone and joint applicationsOffers the background for demographics underlying the market for bone and joint productsContains global market forecasts for regenerative medicines for bone and joint applications, with t ...

Industries : Orthopedic, Therapy

Contract Pharmaceutical Manufacturing, Research and Packaging

$ 4 850
October 2009

Offers a thorough review of the global market for contract manufacturing, research and packaging in the pharmaceutical businessProvides the current global market status for contract manufacturing, research, and packaging and forecasts for growth through 2014Discusses the advantages and disadvantages ...

Industries : Pharmaceutical

OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide

$ 995
September 2009

The OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa). The report includes easily comparable data on mark ...

Industries : Pharmaceutical

Malaysia Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

In BMI?s Business Environment Rating (BER) matrix for Q409, Malaysia considerably improved its positionin the Asia Pacific matrix, and is now ranked fifth out of the 15 key regional markets. Key attractions of theMalaysian pharmaceutical market are the government?s encouragement of the biotechnology ...

Industries : Healthcare, Pharmaceutical

Latvia Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

Prospects for multinationals operating in the Latvian pharmaceutical market remain bleak. The economiccrisis ? highlighted by abysmal GDP data and rocketing unemployment ? is so deep that the effects arefiltering through to the healthcare system. Pharmaceuticals sales in Latvia showed negative year- ...

Industries : Healthcare, Pharmaceutical

Slovakia Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

The Slovakian pharmaceutical market reached EUR1.52bn (US$2.04bn) with per-capita expenditure ofUS$378 in 2008. Drug market expenditure is expected to drop to EUR1.43bn (US$2.02bn) in 2009, withper-capita spending dropping to US$374, despite government-driven measures to curb out-of-pocketexpenditu ...

Industries : Healthcare, Pharmaceutical

Brazil Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

Brazil?s pharmaceutical market was valued at US$16.9bn in 2008. Pharmaceutical sales in Brazil areshowing true resilience to economic troubles in the country, in line with BMI?s expectations for themarket. For Q409 10-year forecasts have been introduced into the Brazil Pharmaceuticals & Healthcarere ...

Industries : Healthcare, Pharmaceutical

Chile Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

In BMI?s Q409 Business Environment Ratings (BER) for the 10 markets of the Americas, Chile?scomposite score continued to worsen, with the country now placed eighth overall. Generally speaking,Chile?s attractiveness as a destination for pharmaceutical investment suffers from low retail prices formedi ...

Industries : Healthcare, Pharmaceutical

Colombia Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

BMI calculates that pharmaceutical sales in Colombia reached COP4,466bn (US$2.27bn) in 2008. Thisrepresents impressive growth of 11.4% in local currency terms between 2007 and 2008 (compared with a-3.2% decline in the drug market between 2006 and 2007). However, our forecast for 2009 is moreconserva ...

Industries : Healthcare, Pharmaceutical

United Arab Emirates Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

For the UAE Q409 Pharmaceuticals and Healthcare Report, BMI expects the total drug market toincrease in value from US$853mn in 2008 to US$1.36bn by 2013, representing a compound annualgrowth rate (CAGR) of 9.8% in US dollar terms. By 2013, drug spending will account for 0.42% of GDP,only a CAGR of 3 ...

Industries : Healthcare, Pharmaceutical

Canada Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

Latest figures from the Canada Patented Medicines Review Board (PMRB) reveal that patented drugspending in Canada is on the rise, evidenced by a 5% increase in sales between 2007 and 2008 to a valueof US$11.7bn. BMI?s figures of US$12.5bn in 2008 closely matched the report, underlining the strengtho ...

Industries : Healthcare, Pharmaceutical

Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery

$ 2 000
September 2009

Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and RecoverySummary?Global Drug Manufacturing Industry Outlook to 2010: Marketing & Sales Strategies and the Impact of Recession and Recovery? is a new report published by Global Markets Di ...

Industries : Drug and Medication

Probiotic Market- Advanced Technologies and Global Market (2009 - 2014)

$ 4 650
September 2009

REPORT DESCRIPTIONThe global probiotics market is estimated to reach US$ 31.2 billion in 2014 growing at a CAGR of 11.7% from 2009 to 2014. In the year 2002, Food and Agriculture Organization (FAO) of the United Nations defined probiotics as ?live microorganisms, which when administered in adequate ...

Industries : Vitamin and Supplement

Global Generic Pharmaceuticals Industry Report

$ 1 313
September 2009

The Global Generic Pharmaceuticals Industry ReportDo you know....The top 7 best trading partners in the industry?Which company has the highest sales growth?Which companies have the highest levels of debt?This report is an in-depth financial evaluation of the Global Generic Pharmaceuticals Industry R ...

Industries : Pharmaceutical

Pharmaceutical Manufacturers Report in China

$ 1 313
September 2009

The Chinese Pharmaceutical Manufacturers ReportDo you know....The top 7 best trading partners in the industry?Which company has the highest sales growth?Which companies have the highest levels of debt?This report is an in-depth financial evaluation of the Chinese Pharmaceutical Manufacturers Indust ...

Industries : Pharmaceutical

<<
< Previous
1
2
3
4
5
6
7
8
9
10
100
Next >
>>

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.